Clinical trial
Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and…
NCT00265005 · University of Louisville, Other · Terminated
Key facts
| NCT number | NCT00265005 |
|---|---|
| Title | Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants |
| Official title | Dose-Ranging, Safety And Efficacy Of Cathflo(TM) Activase(R) (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I |
| Lead sponsor | University of Louisville, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Thrombosis |
| Intervention type | Drug |
| Interventions | alteplase |
| Enrollment | 12 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2012 |
| First posted | Dec 13, 2005 |
| Last update posted | Apr 4, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: